the new generation glocalized patient network in theragenomic and personalized medicine and individualized drug safety
May 05, 2017 –Â This report nicely illustrates how, by both clever study design and selection of according phenotypic patients, genetic predispositions for even very rare serious adverse drug reactions (sARD) can be elucidated, which eventually may lead to theragenomics-based therapy …
Bisphosphonates: GGPS1 Mutation and Atypical Femoral Fractures Read more »
September 01, 2011 – Risk factors for developing renal failure include underlying moderate to severe renal impairment, use of kidney-damaging (nephrotoxic) or diuretic medications at the same time as Zoledronic Acid [Reclast], or severe dehydration occurring before or after Zoledronic …
April 15, 2011 – From a press release as of today, we learn the following (text unchanged from EMEA press release): The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has concluded that rare atypical fractures of …